Itasetron

This classification denotes a 5-ht3 receptor antagonist and antiemetic agent with the molecular formula C16H20N4O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 00S0D0OEKR, chemically known as 2-oxo-n-1alphah,5alphah-tropan-3alpha-yl-1-benzimidazolinecarboxamide but generally known as itasetron, which bears US NIH Compound Identifier 60761. European Medicines Agency schedules Itasetron in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08350MIG. The term ITASETRON is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 7, No3, 1993, List 33). ITASETRON is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule itasetron under HS 29399900 and SITC 54149. As of Q4 2014, ITASETRON remains the US FDA Preferred Term for this commodity. Itasetron bears US NLM identifiers UMLS ID C0526892 and NCI Concept Code C65990. SMILES: O=C(NC1CC2N(C(CC2)C1)C)n1c2c([nH]c1=O)cccc2.